{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,4,4]],"date-time":"2023-04-04T08:10:33Z","timestamp":1680595833254},"reference-count":23,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[1999,1,1]],"date-time":"1999-01-01T00:00:00Z","timestamp":915148800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Clinical Immunology"],"published-print":{"date-parts":[[1999,1]]},"DOI":"10.1006\/clim.1998.4632","type":"journal-article","created":{"date-parts":[[2002,10,6]],"date-time":"2002-10-06T22:17:55Z","timestamp":1033942675000},"page":"22-27","source":"Crossref","is-referenced-by-count":4,"title":["CD40 Stimulation Promotes Human Secondary Immunoglobulin Responses in HuPBL-SCID Chimeras"],"prefix":"10.1006","volume":"90","author":[{"given":"William J.","family":"Murphy","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Satoshi","family":"Funakoshi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"William C.","family":"Fanslow","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Helen C.","family":"Rager","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dennis D.","family":"Taub","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dan L.","family":"Longo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1006\/clim.1998.4632_RF1","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1084\/jem.173.3.705","article-title":"Cytokine-induced proliferation and immunoglobulin production of human B lymphocytes triggered through their CD40 antigen","volume":"73","author":"Rousset","year":"1991","journal-title":"J. Exp. Med."},{"key":"10.1006\/clim.1998.4632_RF2","doi-asserted-by":"crossref","first-page":"1276","DOI":"10.4049\/jimmunol.150.4.1276","article-title":"Immunoregulatory role of CD40 in human B cell differentiation","volume":"150","author":"Splawski","year":"1993","journal-title":"J. Immunol."},{"key":"10.1006\/clim.1998.4632_RF3","doi-asserted-by":"crossref","first-page":"1097","DOI":"10.1084\/jem.178.3.1097","article-title":"B cell activation via CD40 is required for specific antibody production by antigen-stimulated human B cells","volume":"178","author":"Nonoyamas","year":"1993","journal-title":"J. Exp. Med."},{"key":"10.1006\/clim.1998.4632_RF4","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1016\/0952-7915(94)90119-8","article-title":"Tumor necrosis factor receptor superfamily members and their ligands","volume":"6","author":"Armitage","year":"1994","journal-title":"Curr. Opin. Immunol."},{"key":"10.1006\/clim.1998.4632_RF5","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1084\/jem.178.2.669","article-title":"CD40 expression by human monocytes: Regulation by cytokines and activation of monocytes by the ligand for CD40","volume":"178","author":"Alderson","year":"1993","journal-title":"J. Exp. Med."},{"key":"10.1006\/clim.1998.4632_RF6","doi-asserted-by":"crossref","first-page":"1263","DOI":"10.1084\/jem.180.4.1263","article-title":"Activation of human dendritic cells through CD40 cross-linking","volume":"180","author":"Caux","year":"1994","journal-title":"J. Exp. Med."},{"key":"10.1006\/clim.1998.4632_RF7","doi-asserted-by":"crossref","first-page":"1403","DOI":"10.1002\/j.1460-2075.1989.tb03521.x","article-title":"A B-lymphocyte activation molecule related to the nerve growth factor receptor and induced by cytokines in carcinomas","volume":"8","author":"Stamenkovic","year":"1989","journal-title":"EMBO J."},{"key":"10.1006\/clim.1998.4632_RF8","doi-asserted-by":"crossref","first-page":"1097","DOI":"10.1084\/jem.178.3.1097","article-title":"B cell activation via CD40 is required for specific antibody production by antigen-stimulated human B cells","volume":"178","author":"Nonoyama","year":"1993","journal-title":"J. Exp. Med."},{"key":"10.1006\/clim.1998.4632_RF9","doi-asserted-by":"crossref","first-page":"1276","DOI":"10.4049\/jimmunol.150.4.1276","article-title":"Immunoregulatory role of CD40 in human B cell differentiation","volume":"150","author":"Splawski","year":"1993","journal-title":"J. Immunol."},{"key":"10.1006\/clim.1998.4632_RF10","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1006\/smim.1993.1046","article-title":"CD40L: A multi-functional ligand","volume":"5","author":"Armitage","year":"1993","journal-title":"Semin. Immunol."},{"key":"10.1006\/clim.1998.4632_RF11","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1038\/357080a0","article-title":"Molecular and biological characterization of a murine ligand for CD40","volume":"357","author":"Armitage","year":"1992","journal-title":"Nature"},{"key":"10.1006\/clim.1998.4632_RF12","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1016\/0092-8674(93)90668-G","article-title":"The CD40 ligand, gp39, is defective in activated T cells from patients with X-linked hyper-IgM syndrome","volume":"72","author":"Aruffo","year":"1993","journal-title":"Cell"},{"key":"10.1006\/clim.1998.4632_RF13","doi-asserted-by":"crossref","first-page":"990","DOI":"10.1126\/science.7679801","article-title":"CD40 ligand gene defects responsible for X-linked hyper-IgM syndrome","volume":"259","author":"Cutler","year":"1993","journal-title":"Science"},{"key":"10.1006\/clim.1998.4632_RF14","doi-asserted-by":"crossref","first-page":"1567","DOI":"10.1084\/jem.178.5.1567","article-title":"In vivo CD-40-gp39 interactions are essential for thymus-dependent humoral immunity. II. Prolonged supression of the humoral immune response by an antibody to the ligand for CD40, gp39","volume":"178","author":"Foy","year":"1993","journal-title":"J. Exp. Med."},{"key":"10.1006\/clim.1998.4632_RF15","doi-asserted-by":"crossref","first-page":"1555","DOI":"10.1084\/jem.178.5.1555","article-title":"In vivo CD40-gp39 interactions are essential for thymus-dependent humoral immunity. I.in vivo","volume":"178","author":"Van Den Eertwegh","year":"1993","journal-title":"J. Exp. Med"},{"key":"10.1006\/clim.1998.4632_RF16","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/1074-7613(94)90095-7","article-title":"The immune responses in CD40-deficient mice: Impaired immunoglobulin class switching and germinal center formation","volume":"1","author":"Kawabe","year":"1994","journal-title":"Immunity"},{"key":"10.1006\/clim.1998.4632_RF17","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1038\/335256a0","article-title":"Transfer of a functional human immune system to mice with severe combined immunodeficiency","volume":"335","author":"Mosier","year":"1988","journal-title":"Nature"},{"key":"10.1006\/clim.1998.4632_RF18","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1016\/S0065-2776(08)60828-7","article-title":"Adoptive transfer of human lymphoid cells to severely immunodeficient mice: Models for normal human immune function, autoimmunity, lymphomagenesis, and AIDS","volume":"50","author":"Mosier","year":"1991","journal-title":"Adv. Immunol."},{"key":"10.1006\/clim.1998.4632_RF19","doi-asserted-by":"crossref","first-page":"1421","DOI":"10.1002\/eji.1830220614","article-title":"Human-mouse lymphoid chimeras: host-vs.-graft and graft-vs.host reactions","volume":"22","author":"Murphy","year":"1992","journal-title":"Eur. J. Immunol."},{"key":"10.1006\/clim.1998.4632_RF20","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1093\/infdis\/168.3.630","article-title":"Human peripheral blood xenografts in the SCID mouse: characterization of immunological reconstitution","volume":"168","author":"Hesselton","year":"1993","journal-title":"J. Infect. Dis."},{"key":"10.1006\/clim.1998.4632_RF21","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.4049\/jimmunol.148.4.1065","article-title":"Human peripheral blood lymphocytes transplanted into SCID mice constitute anin vivo","volume":"148","author":"Carlsson","year":"1992","journal-title":"J. Immunol."},{"key":"10.1006\/clim.1998.4632_RF22","doi-asserted-by":"crossref","first-page":"1946","DOI":"10.1182\/blood.V86.5.1946.bloodjournal8651946","article-title":"Antibodies to CD40 prevent Epstein-Barr Virus-mediated human B-cell lymphomagenesis in HuPBL-SCID mice","volume":"86","author":"Murphy","year":"1995","journal-title":"Blood"},{"key":"10.1006\/clim.1998.4632_RF23","doi-asserted-by":"crossref","first-page":"1763","DOI":"10.1084\/jem.176.6.1763","article-title":"Lymphoproliferative disease in human peripheral blood mononuclear cell-injected SCID mice. I. T lymphocyte requirement for B cell tumor generation","volume":"176","author":"Veribese","year":"1992","journal-title":"J. Exp. Med."}],"container-title":["Clinical Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1521661698946320?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1521661698946320?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,4,4]],"date-time":"2023-04-04T07:54:49Z","timestamp":1680594889000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1521661698946320"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1999,1]]},"references-count":23,"journal-issue":{"issue":"1","published-print":{"date-parts":[[1999,1]]}},"alternative-id":["S1521661698946320"],"URL":"https:\/\/doi.org\/10.1006\/clim.1998.4632","relation":{},"ISSN":["1521-6616"],"issn-type":[{"value":"1521-6616","type":"print"}],"subject":[],"published":{"date-parts":[[1999,1]]}}}